JP2001186845A - Edible oil-and-fat composition having function to suppress body fat accumulation - Google Patents

Edible oil-and-fat composition having function to suppress body fat accumulation

Info

Publication number
JP2001186845A
JP2001186845A JP37570799A JP37570799A JP2001186845A JP 2001186845 A JP2001186845 A JP 2001186845A JP 37570799 A JP37570799 A JP 37570799A JP 37570799 A JP37570799 A JP 37570799A JP 2001186845 A JP2001186845 A JP 2001186845A
Authority
JP
Japan
Prior art keywords
fat
oil
fatty acid
oils
triglyceride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP37570799A
Other languages
Japanese (ja)
Inventor
Masahiko Nakazoe
真佐彦 中添
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP37570799A priority Critical patent/JP2001186845A/en
Publication of JP2001186845A publication Critical patent/JP2001186845A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide an edible oil-and-fat composition capable of suppressing increase of blood triglyceride (neutral fat) level as one of the causes of arteriosclerosis, slight in accumulation tendency in the body, and excellent in preservation stability and flavor while having versatility equivalent to conventional edible oil (usable in place of an ordinary cooking oil). SOLUTION: This edible oil-and-fat composition having the function to suppress body fat accumulation is characterized by that the triglyceride has a 2-10C fatty acid component at 2-site and >=16C fatty acid components at 1- and 3-sites.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、一般に使用されて
いる食用油脂と比較して、食後の血中トリグリセリド
(中性脂肪)の増加が抑制され、体への蓄積性が少な
く、しかも加熱安定性、保存安定性及び風味が良好で汎
用性がある食用油脂組成物に関するものである。
[0001] The present invention relates to an edible oil and fat, which suppresses an increase in postprandial blood triglyceride (neutral fat), has less accumulation in the body, and is heat stable. The present invention relates to an edible oil / fat composition having good versatility, storage stability and flavor.

【0002】[0002]

【従来の技術】近年、日本の食生活においては脂質の摂
取量が増大しており、実際ここ50年で摂取エネルギー
における脂質の占める割合は3倍に増加している。この
ことは血中トリグリセリド(中性脂肪)濃度の増加、肥
満を招き、成人病増加の大きな原因となっている。血中
トリグリセリド(中性脂肪)値及び血中コレステロール
値は動脈硬化と密接に関係しているため、これらの値を
低く保つことは成人病予防の点で特に大切なことであ
る。脂質摂取量の増加は、油脂が美味しい食事に欠かせ
ない栄養素であるためである。そのため、これまで脂質
摂取量を減らす目的で、蛋白や糖を利用した油脂代替物
が開発されてきた。
2. Description of the Related Art In recent years, the dietary intake of lipids has been increasing in Japanese dietary habits, and in fact, in the last 50 years, the proportion of lipids in the energy intake has tripled. This leads to an increase in blood triglyceride (triglyceride) concentration, obesity, and is a major cause of an increase in adult diseases. Since blood triglyceride (triglyceride) and blood cholesterol levels are closely related to arteriosclerosis, keeping these levels low is particularly important in preventing adult diseases. The increase in fat intake is due to the fact that fats and oils are essential nutrients in a delicious diet. Therefore, in order to reduce lipid intake, fat and oil substitutes using proteins and sugars have been developed.

【0003】しかし、これらの代替物は、油脂の重要な
機能である調理等の熱媒体としての役割を代替すること
は不可能である。そこで、現在使用している油脂と同等
の風味、食感及び物理的性質を有し、しかも熱媒体とし
て使用でき、さらに食後の血中トリグリセリド(中性脂
肪)増加を抑えることが出来る油脂が開発できれば、肥
満を防ぎさらには成人病の発病率を低下させることが可
能になると考えられる。この様な油脂としては近年開発
が盛んに行われている非吸収性油脂がある。たとえばシ
ョ糖脂肪酸ポリエステル(米国特許第3,600,18
6号明細書)があり、これは体内で吸収されず排泄され
るため油脂由来のカロリーは0となるが、非吸収性の油
脂であるため、肛門漏洩、脂溶性ビタミン吸収阻害等の
問題がある。中鎖脂肪酸トリグリセリド(MCT)は、
体内で非蓄積であることが公知のこととして知られてい
る。しかし、加熱調理に使用した際、低い発煙点(16
0℃以下)が問題であり、フライ油及び炒め油として使
用することは困難である。
[0003] However, these substitutes cannot replace the role as a heating medium for cooking or the like, which is an important function of fats and oils. Therefore, an oil and fat that has the same flavor, texture and physical properties as the oils and fats currently used, can be used as a heat medium, and can suppress an increase in blood triglyceride (neutral fat) after eating has been developed. If possible, it would be possible to prevent obesity and further reduce the incidence of adult diseases. Such fats and oils include non-absorbable fats and oils which have been actively developed in recent years. For example, sucrose fatty acid polyesters (US Pat. No. 3,600,18)
No. 6 specification), which is excreted without being absorbed in the body, and therefore has zero calories derived from fats and oils. However, since it is a non-absorbable fat, there are problems such as anal leakage and inhibition of fat-soluble vitamin absorption. is there. Medium-chain fatty acid triglyceride (MCT)
It is known to be non-accumulating in the body. However, when used for cooking, a low smoke point (16
(0 ° C. or less) is a problem, and it is difficult to use it as frying oil or stir-fry oil.

【0004】長鎖飽和脂肪酸(たとえばベヘン酸)及び
炭素数10以下の中鎖脂肪酸を含有したトリグリセリド
(特開平2−1799号公報)及び長鎖飽和脂肪酸(た
とえばステアリン酸)及び短鎖脂肪酸を含有したトリグ
リセリド(特表平6−506106号公報)は、生体内
で難吸収性の長鎖飽和脂肪酸と体内非蓄積性の中鎖脂肪
酸もしくは短鎖脂肪酸を含有しているため、食後の血中
トリグリセリド(中性脂肪)増加を抑え、成人病予防用
油脂代替物としての使用が期待できるが、性状が固体脂
であるため汎用性が乏しくなる。特開平10−1761
81号には油脂中に1,3−ジグリセリドを40モル%
以上含有し、モノグリセリドを1.5重量%未満含有す
る油脂組成物であって、且つ油脂中のジグリセリドの構
成脂肪酸中、93重量%以上が不飽和脂肪酸である液状
汎用型油脂組成物が開示されている。これらジグリセリ
ドを含有する油脂は通常のトリグリセリド主体の油脂と
比較して、ジグリセリド特有の風味、刺激があり、むし
ろ、乳化剤のモノグリセリドに類似した味覚を有するな
ど、風味に問題がある。さらに発煙点が180℃以下で
あり、また不飽和脂肪酸含量が多いために加熱安定性が
低いなどフライ油及び炒め油としての使用に問題があ
る。
[0004] Triglycerides containing long-chain saturated fatty acids (for example, behenic acid) and medium-chain fatty acids having 10 or less carbon atoms (Japanese Patent Laid-Open No. 2-1799), and long-chain saturated fatty acids (for example, stearic acid) and short-chain fatty acids are contained. Triglyceride (Japanese Patent Publication No. 6-506106) contains a long-chain saturated fatty acid that is hardly absorbed in vivo and a medium- or short-chain fatty acid that is not accumulated in the body. (Neutral fat) It can be expected to be used as a substitute for fats and oils for preventing adult diseases by suppressing the increase, but the general versatility is poor because the properties are solid fats. JP-A-10-1761
No. 81 contains 40 mol% of 1,3-diglyceride in fats and oils.
A liquid general-purpose fat / oil composition comprising the above-mentioned monoglyceride and less than 1.5% by weight of a fatty acid composition, wherein 93% by weight or more of the fatty acid constituting diglyceride in the fat / oil is an unsaturated fatty acid. ing. These diglyceride-containing fats and oils have a taste and irritation peculiar to diglyceride as compared with ordinary triglyceride-based fats and oils, and have a taste problem such as having a taste similar to monoglyceride as an emulsifier. Further, there is a problem in use as a frying oil and a stir-fry oil because the smoke point is 180 ° C. or lower and the heating stability is low due to the large content of unsaturated fatty acids.

【0005】一方、トリグリセリドの2位の脂肪酸が炭
素数8〜14(C8〜C14)であり、1,3位の脂肪
酸が炭素数18(C18)以上であることを特徴とする
消化吸収性の良い油脂も知られている(特公平4−12
920号)が、この油脂は、長鎖高度不飽和脂肪酸の摂
取が血清コレステロールを低下し、脳血栓の予防効果を
有すること、ならびに中鎖脂肪酸も血清コレステロール
低下効果を持つことなどから、これらの脂肪酸を摂取す
ることが健康の維持に役立つため、これらの脂肪酸を体
内に消化吸収されやすいトリグリセリド組成にしたもの
で、主に栄養剤または静脈注射用の油脂として用いるこ
とを目的としている。従って、この油脂は、血中トリグ
リセリド(中性脂肪)の吸収、増加を抑え、体内への脂
肪の蓄積を抑制する効果を持つ本発明の主として揚げ物
用などの調理に使用する油脂とは、作用効果の全く異な
る異質の油脂と言えるものである。
On the other hand, the fatty acid at position 2 of triglyceride has 8 to 14 carbon atoms (C8 to C14), and the fatty acid at position 1 and 3 has 18 or more carbon atoms (C18). Good oils and fats are also known.
No. 920), because the fats and oils reduce serum cholesterol and prevent cerebral thrombosis by ingestion of long-chain highly unsaturated fatty acids, and medium-chain fatty acids also have serum cholesterol lowering effects. Since ingestion helps to maintain health, these fatty acids have a triglyceride composition that is easily digested and absorbed in the body, and are intended to be used mainly as nutritional supplements or oils and fats for intravenous injection. Therefore, this fat and oil has the effect of suppressing the absorption and increase of triglyceride (neutral fat) in blood and suppressing the accumulation of fat in the body. It can be said to be a different kind of fat and oil with completely different effects.

【0006】[0006]

【発明が解決しようとする課題】本発明の目的は、従来
の油と同等の汎用性(通常の調理油に代えて使用可能)
を有しながら、動脈硬化の原因の一つである血中トリグ
リセリド(中性脂肪)の増加を抑制し、体内への蓄積性
が少なく、しかも保存安定性及び風味が良好である食用
油脂組成物を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide the same general versatility as conventional oils (can be used in place of ordinary cooking oil).
An edible oil / fat composition which suppresses an increase in blood triglyceride (neutral fat), which is one of the causes of arteriosclerosis, has low accumulation in the body, and has good storage stability and flavor Is to provide.

【0007】[0007]

【課題を解決するための手段】そこで本発明者は、上記
課題を解決すべく種々検討した結果、トリグリセリドの
2位の脂肪酸及び1,3位の脂肪酸が特定組成である食
用油脂が、通常の食用油よりも食後の血中トリグリセリ
ド(中性脂肪)の増加が起こりにくく、しかも体脂肪蓄
積及び内臓脂肪への蓄積が軽減されることを見出して本
発明を完成した。すなわち、本発明は、トリグリセリド
の2位の脂肪酸が炭素数2〜10(C2〜C10)であ
り、1,3位の脂肪酸が炭素数16(C16)以上であ
ることを特徴とする体脂肪蓄積抑制機能を有する食用油
脂脂肪組成物である。
The present inventors have conducted various studies to solve the above-mentioned problems, and as a result, have found that edible oils and fats having a specific composition of the 2-position fatty acid and the 1- and 3-position fatty acids of triglyceride are commonly used. The present inventors have found that blood triglycerides (neutral fats) are less likely to increase after meals than edible oils, and that body fat accumulation and accumulation in visceral fat are reduced, thereby completing the present invention. That is, the present invention is characterized in that the fatty acid at position 2 of triglyceride has 2 to 10 carbon atoms (C2 to C10) and the fatty acid at position 1 and 3 has 16 or more carbon atoms (C16). It is an edible fat / oil composition having an inhibitory function.

【0008】[0008]

【発明の実施の形態】以下、本発明について詳細に説明
する。本発明油脂は2位にC2〜C10の脂肪酸を多く
含むため通常の油脂の構造と異なり、摂取後、十二指腸
で加水分解されると、生成する2位にのみ脂肪酸が結合
したモノグリセリド量が減少し、その結果、小腸上皮細
胞でのトリグリセリドの再合成が抑制され、リンパ管中
の血中トリグリセリド(中性脂肪)が低下し、体脂肪蓄
積及び内臓脂肪への蓄積軽減効果につながる。よって、
「血中トリグリセリド(中性脂肪)の増加抑制」、「体
脂肪蓄積軽減」及び「内臓脂肪蓄積軽減」という効果を
発現しなおかつ、通常の食用油としての汎用性を持つた
めには、トリグリセリドの2位の脂肪酸がC2〜C10
であり、1,3位の脂肪酸がC16以上であることが必
須である。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail. The fats and oils of the present invention contain a large amount of C2-C10 fatty acids at the 2nd position, which is different from the structure of normal fats and oils. When ingested and hydrolyzed in the duodenum, the amount of monoglyceride bound to the 2nd position is reduced. As a result, the resynthesis of triglyceride in the small intestinal epithelial cells is suppressed, and the blood triglyceride (neutral fat) in lymphatic vessels is reduced, leading to an effect of reducing body fat accumulation and accumulation in visceral fat. Therefore,
In order to exhibit the effects of “suppressing increase in blood triglyceride (neutral fat)”, “reducing body fat accumulation” and “reducing visceral fat accumulation” and to have general versatility as an ordinary edible oil, triglyceride must be 2nd fatty acid is C2-C10
It is essential that the 1,3-position fatty acid is C16 or more.

【0009】本発明においては、汎用性の液状油脂であ
るという観点より、用途としては汎用型食用油(例えば
調理油)が考えられる。そのため、通常調理が行われる
温度(180℃)以上の発煙点を有することが好まし
い。より好ましくは190℃以上、更に好ましくは20
0℃以上である。また風味の点より、油脂組成物中のジ
グリセリド含量が10重量%未満、モノグリセリド含量
が1.5重量%未満、酸価(AV)は1.0以下である
ことが望ましい。
In the present invention, general-purpose edible oils (for example, cooking oils) are conceivable as applications from the viewpoint of being general-purpose liquid fats and oils. Therefore, it is preferable to have a smoke point higher than the temperature (180 ° C.) at which normal cooking is performed. More preferably 190 ° C. or higher, still more preferably 20 ° C.
0 ° C. or higher. From the viewpoint of flavor, it is desirable that the diglyceride content in the oil and fat composition is less than 10% by weight, the monoglyceride content is less than 1.5% by weight, and the acid value (AV) is 1.0 or less.

【0010】本油脂組成物の主なる使用目的は汎用型食
用油(例えば調理油)であるため、保存状態において結
晶生成及び固化が起こっては都合が悪い。このことよ
り、冷蔵庫内で保存した場合、結晶生成及び固化が起こ
らない条件として、1,3位の脂肪酸の不飽和脂肪酸含
有量が82モル%以上であることが必要である。また、
本発明の食用油脂組成物は揚げ物用途において、通常の
油脂と併用することもできるが本発明の効果を十分に発
揮させるためには、本発明の食用油脂組成物が少なくと
も40%モル以上になることが必須である。
[0010] Since the main purpose of using the present fat and oil composition is a general-purpose edible oil (eg, cooking oil), it is inconvenient if crystal formation and solidification occur in a stored state. From this, it is necessary that the unsaturated fatty acid content of the fatty acid at the 1,3-position is 82 mol% or more as a condition under which crystal formation and solidification do not occur when stored in a refrigerator. Also,
The edible oil / fat composition of the present invention can be used in combination with ordinary fats and oils for use in frying, but in order to sufficiently exert the effects of the present invention, the edible oil / fat composition of the present invention is at least 40% mol or more. It is essential.

【0011】[0011]

【実施例】以下に実施例をもって本発明の効果をより詳
細に説明するが、本発明はこれらの例に限定されるもの
ではない。
EXAMPLES The effects of the present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.

【0012】〔油脂の調製〕 グリセリンと菜種油由来
の脂肪酸を市販の1,3位特異性のリバーゼを用いて公
知の方法にてエステル化を行い、1,3−ジアシルグリ
セリドを得た。試作油脂1は上記により得た1,3−ジ
アシルグリセリドと無水酢酸を加熱した後、反応混合物
を分子蒸留にかけ、常法によって精製を行って得た。試
作油脂2は無水酢酸の代わりにカプロン酸無水物を用い
る以外は試作油脂1と同様の操作により得た。試作油脂
3は無水酢酸の代わりにカプリル酸無水物を用いる以外
は試作油脂1と同様の操作により得た。試作油脂4は無
水酢酸の代わりにカプリン酸無水物を用いる以外は試作
油脂1と同様の操作により得た。試作油脂5は試作油脂
2を菜種油と45:55の比率で混合することにより得
た。
[Preparation of Oil and Fat] Glycerin and rapeseed oil-derived fatty acid were esterified by a known method using a commercially available 1,3-specific rivase to obtain 1,3-diacylglyceride. The prototype oil 1 was obtained by heating the 1,3-diacylglyceride and acetic anhydride obtained above, then subjecting the reaction mixture to molecular distillation and purifying by a conventional method. Trial oil 2 was obtained in the same manner as trial oil 1 except that caproic anhydride was used instead of acetic anhydride. Trial oil 3 was obtained in the same manner as trial oil 1 except that caprylic anhydride was used instead of acetic anhydride. Trial oil 4 was obtained by the same operation as trial oil 1 except that capric anhydride was used instead of acetic anhydride. The trial oil 5 was obtained by mixing the trial oil 2 with rapeseed oil at a ratio of 45:55.

【0013】比較油脂1は無水酢酸の代わりにラウリン
酸無水物を用いる以外は試作油脂1と同様の操作により
得た。比較油脂2は試作油脂2を菜種油と35:65の
比率で混合することにより得た。比較油脂3はトリカプ
ロン:菜種油を1:2で混合して得た。比較油脂4はト
リカプロン:菜種油を1:2で混合し、化学的にランダ
ムにエステル交換して得た。尚、各油脂の構成脂肪酸組
成(重量%)及びトリグリセリドの組成は、以下の表1
に示した。
The comparative fat 1 was obtained by the same operation as the trial fat 1 except that lauric anhydride was used instead of acetic anhydride. Comparative fat 2 was obtained by mixing prototype fat 2 with rapeseed oil in a ratio of 35:65. Comparative fat 3 was obtained by mixing tricapron: rapeseed oil in a ratio of 1: 2. Comparative fat 4 was obtained by mixing tricapron: rapeseed oil at a ratio of 1: 2 and chemically transesterifying them randomly. In addition, the constituent fatty acid composition (% by weight) and the composition of triglyceride of each fat and oil are shown in Table 1 below.
It was shown to.

【0014】 [0014]

【0015】 上記のトリグリセリド組成中、例えばL2Lは1,3位
にC16以上の脂肪酸が結合し、2位にC2の脂肪酸が
結合したトリグリセリドを示す。他も同様の意味のトリ
グリセリドを示す。
[0015] In the above triglyceride composition, for example, L2L indicates a triglyceride in which a C16 or higher fatty acid is bonded to the 1,3-position and a C2 fatty acid is bonded to the 2-position. Others show the triglyceride of the same meaning.

【0016】実施例1 各種油脂10%、牛血清アルブミン2%、卵黄レシチン
0.2%及び蒸留水87.8%を含む混合液を高圧乳化
機を用いて乳化し、本乳剤を18時間絶食させた13週
齢SDラットにラット体重100g当たり0.73ml
となるように経口投与し、各採血時間群(0、0.5、
1.0、3.0時間)(各群5匹)ごとに採血し、血中
トリグリセリド量変化を観察した。結果を表2に示す。
Example 1 A mixture containing 10% of various fats and oils, 2% of bovine serum albumin, 0.2% of egg yolk lecithin and 87.8% of distilled water was emulsified using a high-pressure emulsifier, and this emulsion was fasted for 18 hours. 0.73 ml per 100 g of rat body weight
Oral administration was performed so that each blood collection time group (0, 0.5,
(1.0, 3.0 hours) (five animals per group), and blood triglyceride level changes were observed. Table 2 shows the results.

【0017】 [0017]

【0018】 * 菜種油投与群の同時間値に対し、有意(t<0.01)に血中トリグリセリド が抑制 ** 菜種油投与群の同時間値に対し、有意(t<0.05)に血中トリグリセリド が抑制 [0018] * Blood triglyceride was significantly (t <0.01) significantly lower than the same time value in the rapeseed oil administration group ** Blood triglyceride was significantly (t <0.05) significantly reduced in the rapeseed oil-administered group at the same time

【0019】試作油脂1、2、3で飼育したラット群
は、菜種油を投与したラット群と比較し、有意(t<
0.01)に血中トリグリセリド(中性脂肪)増加が抑
制されており、また試作油脂4、5で飼育したラット群
は、菜種油を投与したラット群と比較し、有意(t<
0.05)に血中トリグリセリド(中性脂肪)増加が抑
制されており、試作油脂1〜5は、食後の血中トリグリ
セリド(中性脂肪)増加を抑制する油脂であることがわ
かる。一方、比較油脂1〜4は、菜種油を投与したラッ
ト群と比較して血中トリグリセリド(中性脂肪)増加が
抑制されなかった。
The groups of rats bred with the trial oils 1, 2 and 3 were significantly (t <
0.01), the increase in blood triglyceride (neutral fat) was suppressed, and the group of rats bred with trial oils 4 and 5 was significantly (t <
At 0.05), the increase in blood triglyceride (neutral fat) is suppressed, and it is understood that the prototype oils 1 to 5 are oils and fats that suppress the increase in blood triglyceride (neutral fat) after eating. On the other hand, in Comparative Oils 1 to 4, the increase in blood triglyceride (neutral fat) was not suppressed as compared with the rat group to which rapeseed oil was administered.

【0020】実施例2 各食餌とも6週齢SD系ラットを10匹用い、表3に示
す餌をラットに与えて3週間飼育した時の体重変化と体
脂肪率変化を表4に示す。なお、体脂肪率の測定は、電
導率を利用した小動物用体脂肪率測定装置を用いて測定
した。
Example 2 Table 4 shows changes in body weight and body fat percentage when 10 rats of 6 weeks old were used for each diet and the rats were fed the diets shown in Table 3 and reared for 3 weeks. The body fat percentage was measured using a small animal body fat percentage measuring device using electrical conductivity.

【0021】 [0021]

【0022】 [0022]

【0023】 * 菜種油投与群の同時間値に対し、有意(t<0.01)に血中トリグリセリド が抑制** 菜種油投与群の同時間値に対し、有意(t<0.05)に血中トリグリセリド が抑制 [0023] * Blood triglyceride was significantly (t <0.01) significantly reduced (t <0.01) compared to the same time in the rapeseed oil group. ** Blood triglyceride was significantly (t <0.05) significantly reduced (t <0.05) in the rapeseed oil group. Suppression

【0024】試作油脂1、2、3で飼育したラット群
は、菜種油を投与したラット群と比較し、有意(t<
0.01)に体脂肪率が低下しており、また試作油脂
4、5で飼育したラット群は、菜種油を投与したラット
群と比較し、有意(t<0.05)に体脂肪率が低下し
ており、試作油脂1〜5は、食後の血中トリグリセリド
(中性脂肪)増加を抑制する油脂であることがわかる。
一方、比較油脂1〜4は、菜種油を投与したラット群と
比較して体脂肪率が低下しなかった。
The groups of rats bred with the experimental oils 1, 2, and 3 were significantly (t <
0.01), and the rat group bred with the prototype oils 4 and 5 showed a significant (t <0.05) increase in the body fat percentage compared to the rat group receiving rapeseed oil. It can be seen that the prototype oils 1 to 5 are oils and fats that suppress an increase in blood triglyceride (neutral fat) after eating.
On the other hand, the comparative fats and oils 1-4 did not decrease the body fat percentage as compared with the rat group to which the rapeseed oil was administered.

【0025】実施例3 調理評価により調製油の汎用性を評価した。この油脂を
用いて揚げ物料理を行った結果を示す。調理油としての
評価は、下記の材料を用いて天ぷらを作り、その時の発
煙の仕方、発泡、風味を専門のパネラーが評価した。結
果を表5に示した。 調理評価に使用した材料: 油300g、海老2尾、南瓜2切れ バッター組成: 卵50g、水150g、小麦粉100g フライ温度 180℃
Example 3 The versatility of the prepared oil was evaluated by cooking evaluation. The result of having performed fried food cooking using this fat and oil is shown. For the evaluation as cooking oil, a tempura was prepared using the following materials, and the method of smoking, foaming, and flavor at that time were evaluated by a specialized panelist. Table 5 shows the results. Ingredients used for cooking evaluation: 300g oil, 2 shrimp, 2 slices of squash Batter composition: 50g egg, 150g water, 100g flour Fry temperature 180 ° C

【0026】 [0026]

【0027】 [0027]

【0028】上記結果より、試作油脂1〜5は発煙・発
泡が起こらず、調理作業性も良好で、風味も良く、通常
油と同等に使用できる油脂であることがわかった。一
方、比較油脂3は、風味が悪く、しかも発煙・発泡が起
こり、揚げ物料理には使用出来ないことが判明した。
From the above results, it was found that the prototype fats and oils 1 to 5 did not cause smoke and foaming, had good cooking workability, had a good flavor, and could be used as a normal oil. On the other hand, it was found that the comparative fat 3 had an inferior flavor, smoked and foamed, and could not be used for fried foods.

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 9/10 101 A61P 9/10 101 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (Reference) A61P 9/10 101 A61P 9/10 101

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 トリグリセリドの2位の脂肪酸が炭素数
2ないし10であり、1,3位の脂肪酸が炭素数16以
上であることを特徴とする体脂肪蓄積抑制機能を有する
食用油脂組成物。
An edible oil / fat composition having a body fat accumulation-suppressing function, wherein the fatty acid at position 2 of triglyceride has 2 to 10 carbon atoms and the fatty acid at positions 1 and 3 has 16 or more carbon atoms.
【請求項2】 1,3位の脂肪酸中82重量%以上が不
飽和脂肪酸である請求項1に記載の食用組成物。
2. The edible composition according to claim 1, wherein at least 82% by weight of the 1,3-position fatty acid is an unsaturated fatty acid.
【請求項3】 発煙点が180℃以上である請求項1ま
たは2に記載の食用油脂組成物。
3. The edible fat / oil composition according to claim 1, wherein the smoke point is 180 ° C. or higher.
【請求項4】 請求項1ないし3に記載の食用油脂組成
物を少なくとも40モル%以上含んでなる調理用油脂組
成物。
4. A cooking fat and oil composition comprising at least 40 mol% of the edible fat and oil composition according to claim 1.
【請求項5】 調理が油ちょうである請求項4に記載の
油脂組成物。
5. The oil or fat composition according to claim 4, wherein the cooking is fried.
JP37570799A 1999-12-28 1999-12-28 Edible oil-and-fat composition having function to suppress body fat accumulation Pending JP2001186845A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP37570799A JP2001186845A (en) 1999-12-28 1999-12-28 Edible oil-and-fat composition having function to suppress body fat accumulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP37570799A JP2001186845A (en) 1999-12-28 1999-12-28 Edible oil-and-fat composition having function to suppress body fat accumulation

Publications (1)

Publication Number Publication Date
JP2001186845A true JP2001186845A (en) 2001-07-10

Family

ID=18505932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP37570799A Pending JP2001186845A (en) 1999-12-28 1999-12-28 Edible oil-and-fat composition having function to suppress body fat accumulation

Country Status (1)

Country Link
JP (1) JP2001186845A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001226693A (en) * 2000-02-18 2001-08-21 Nisshin Oil Mills Ltd:The Oils-and-fats composition
WO2003056928A1 (en) * 2001-12-28 2003-07-17 The Nisshin Oillio, Ltd. Fat and oil compositions for decreasing blood lipid
JP2003265104A (en) * 2002-03-18 2003-09-24 Honen Corp Oil-and-fat composition
US20230223101A1 (en) * 2022-01-10 2023-07-13 Climax Foods Inc. Compositions and methods for acylated consumables

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001226693A (en) * 2000-02-18 2001-08-21 Nisshin Oil Mills Ltd:The Oils-and-fats composition
WO2003056928A1 (en) * 2001-12-28 2003-07-17 The Nisshin Oillio, Ltd. Fat and oil compositions for decreasing blood lipid
US6827963B2 (en) 2001-12-28 2004-12-07 The Nisshin Oillio, Ltd. Fats and oils composition for reducing lipids in blood
JP2003265104A (en) * 2002-03-18 2003-09-24 Honen Corp Oil-and-fat composition
US20230223101A1 (en) * 2022-01-10 2023-07-13 Climax Foods Inc. Compositions and methods for acylated consumables

Similar Documents

Publication Publication Date Title
JP3569116B2 (en) Liquid general-purpose fat composition
JP4733246B2 (en) Oil composition
EP0836805B1 (en) General-purpose oil composition
CA2417971C (en) Oil/fat composition
JP2010279381A (en) Oil or fat composition and method for producing oil or fat composition
JP4381037B2 (en) Oil composition
US6762203B2 (en) Oil composition
US20020132035A1 (en) Synthetic fat composition
JP3599821B2 (en) Cooking fats and oils
JP2002138297A (en) Oil and fat composition
JP2017046688A (en) Beverage composition for weight gain inhibition
CA2168051A1 (en) Reduced calorie fat component
JP5099808B2 (en) Composition for improving lipid metabolism
WO1998039977A1 (en) Food containing fat or oil
JP2003534356A (en) An oil composition comprising short, medium and long chain triglycerides and its use for reducing weight gain.
JP2001161265A (en) Oil and fat composition
JP3482253B2 (en) Cooking fats and oils
JP3850840B2 (en) Low calorie food
JP2001186845A (en) Edible oil-and-fat composition having function to suppress body fat accumulation
JPH0284151A (en) Meat product having reduced animal fat and calorie
JP4046438B2 (en) Oil composition
JP2004075653A (en) Adipose decomposition accelerator and food or beverage
WO2007129439A1 (en) Inhibitor of increase in postprandial blood insulin level
JP2003265104A (en) Oil-and-fat composition
JP2005065645A (en) Edible oil and fat composition